Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
The Dow surges 500 points as Trump hands out some tariff relief

In This Article:

Photo: Spencer Platt (Getty Images)
Photo: Spencer Platt (Getty Images)

The Dow Jones Industrial Average rose by nearly 500 points, recovering from a steep decline earlier in the week as the major U.S. automakers are given a one-month exemption from new tariffs on Canadian and Mexican imports.

“We spoke with the Big Three auto dealers. We are going to give a one month exemption on any autos coming through USMCA,” President Donald Trump said, according to a statement provided by White House Press Secretary Karoline Leavitt during a news conference.

The news follows comments from Commerce Secretary Howard Lutnick, who indicated that there might be potential tariff relief for Canada and Mexico. He suggested that the U.S. could be moving toward a compromise that is a “middle ground.

As the day ended in New York, the S&P 500 added 1.1%, while the Nasdaq 100 climbed 1.4%. The Dow Jones Industrial Average added 485 points or 1.1%. Meanwhile, the job report came weak, raising concerns about stagflation.

General Motors and Ford surges on tariff relief

General Motors (GM) stock surged more than 3% as the broader market rebounded in the morning. The rally appeared to be driven by investor optimism following Lutnick’s remarks suggesting potential tariff relief for Canada and Mexico.

Meanwhile, Ford (F) also jumped 5% in the afternoon following the news.

Moderna jumps as CEO purchasesshares

Shares of pharmaceutical giant Moderna (MRNA+8.96%) surged over 6% on Wednesday after strategic insider stock purchases by the company’s CEO and a board director. According to a recent Securities and Exchange Commission (SEC) filing, CEO Stephane Bancel and board director Paul Sagan acquired $6 million worth of Moderna shares.

Novo Nordisk plans to sell Wegovy at half price

Shares of Novo Nordisk (NVO+3.93%) climbed 3.5% after the company announced plans to sell its weight loss drug Wegovy at less than half its usual monthly price through a new direct-to-consumer online pharmacy.

CrowdStrike is down on weak guidance

CrowdStrike (CRWD) stock fell 9% on Wednesday after the cybersecurity software company provided disappointing earnings guidance. The company gained significant attention last year following a widespread global tech outage linked to its software.

— William Gavin contributed to the article

For the latest news, Facebook, Twitter and Instagram.